By: ICN Bureau
Last updated : August 14, 2025 2:49 pm
Anupam Rasayan’s order book now stands at Rs.14,646 crore
Anupam Rasayan India Ltd., one of India’s leading custom synthesis and specialty chemical player, has announced its financial results for the quarter ended June 30, 2025.
During the quarter, the company reported total revenue Rs. 490.7 crore as compared to Rs. 260.3 crore in Q1 FY25; up 89 per cent YoY. EBITDA (incl. other income) was at Rs. 129.2 crore in Q1FY26 as compared to Rs. 59.2 crore in Q1 FY25, up 118 per cent and this would translate into 26 per cent EBITDA margin in this quarter.
Profit After Tax was at Rs. 48.5 crore in Q1 FY26 as compared to Rs. 12.2 crore in Q1 FY25; up 297 per cent YoY.
Speaking on the performance, Anand Desai, Managing Director, Anupam Rasayan commented, “During Q1 FY26, consolidated revenue stood at Rs. 491 crore, registering a robust growth of 89% year-on-year. We strongly believe that the sectoral trends are in our favour, and we are witnessing a clear resurgence in growth. Our pharma and polymer businesses are performing well, coupled with recovery in Agrochemical segment.
The USA and Japan markets have shown encouraging trends for Anupam Rasayan. During Q1 FY26, total exports accounted for 58% of the total revenue from operations.
With the two new agreements signed with Japanese and US-based multinational companies, our order book now stands at Rs.14,646 crore, reflecting the strong growth momentum in our business.”